Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/899866/000114036120028237/nc10017928x1_8k.htm
July 2021
July 2021
May 2021
May 2021
April 2021
March 2021
February 2021
February 2021
January 2021
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/899866/000114036120028237/nc10017928x1_8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Alexion Pharmaceuticals, Inc..
Alexion Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Alexion Pharmaceuticals, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ALXNEvents:
CIK: 899866
Form Type: 8-K Corporate News
Accession Number: 0001140361-20-028237
Submitted to the SEC: Mon Dec 14 2020 9:05:44 AM EST
Accepted by the SEC: Mon Dec 14 2020
Period: Saturday, December 12, 2020
Industry: Pharmaceutical Preparations